Jeffrey M. Crane

Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma

C. Lance Cowey, Chirag Amin, Raj S. Pruthi et al. · Journal of Clinical Oncology · 2010 · 197 citations · Full text

A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer

Young E. Whang, Andrew J. Armstrong, W. Kimryn Rathmell et al. · Urologic Oncology Seminars and Original Investigations · 2011 · 85 citations

Urology, Genitourinary Cancer, Medicine +7

Results of therapeutic cranial irradiation in small cell lung cancer

James Carmichael, Jeffrey M. Crane, Paul A. Bunn et al. · International Journal of Radiation Oncology*Biology*Physics · 1988 · 71 citations

Radiation Therapy, Medicine, Therapeutic Cranial Irradiation +6

A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer

Thomas E. Stinchcombe, Amy H. Peterman, Carrie B. Lee et al. · Journal of Thoracic Oncology · 2011 · 36 citations · Full text

Oncology, Elderly Patients, Medicine +7

Using Survivorship Care Plans to Enhance Communication and Cancer Care Coordination: Results of a Pilot Study

Deborah K. Mayer, Allison M. Deal, Jeffrey M. Crane et al. · Oncology nursing forum · 2016 · 33 citations